Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: Report from the SENTRY Antimicrobial Surveillance Program

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1491-1493

  Jones, Ronald N ^a,b   Stilwell, Matthew G ^a   Hogan, Patricia A ^c   Sheehan, Daniel J ^c  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS; BACILLUS CEREUS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CORYNEBACTERIUM; CORYNEBACTERIUM JEIKEIUM; CORYNEBACTERIUM PSEUDODIPHTHERIAE; CORYNEBACTERIUM STRIATUM; DRUG POTENCY; ENTEROCOCCUS AVIUM; ENTEROCOCCUS DURANS; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ENTEROCOCCUS RAFFINOSUS; GRAM POSITIVE BACTERIUM; LISTERIA MONOCYTOGENES; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ROTHIA MUCILAGINOSA;

ACETAMIDES; ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; POPULATION SURVEILLANCE;

EID: 34247163020     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01496-06     Document Type: Article

References (21)

1. Anderegg, T. R., H. S. Sader, T. R. Fritsche, J. E. Ross, and R. N. Jones. 2005. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program. Int. J. Antimicrob. Agents 26:13-21.
2. Ballow, C. H., D. J. Biedenbach, F. Rossi, and R. N. Jones. 2002. Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and E-test methods: report of the Zyvox® antimicrobial potency study in Latin America (LA-ZAPS). Braz. J. Infect. Dis. 6:100-109.
3. Ballow, C. H., R. N. Jones, and D. J. Biedenbach. 2002. A multicenter evaluation of linezolid antimicrobial activity in North America. Diagn. Microbiol. Infect. Dis. 43:75-83.
4. Bell, J. M., J. D. Turnidge, C. H. Ballow, and R. N. Jones. 2003. Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific. J. Antimicrob. Chemother. 51:339-345.
5. Bolmstrom, A., C. H. Ballow, A. Qwarnstrom, D. J. Biedenbach, and R. N. Jones. 2002. Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe). Clin. Microbiol. Infect. 8:791-800.
6. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Diekema, D. J., and R. N. Jones. 2001. Oxazolidinone antibiotics. Lancet 358:1975-1982.
9. Draghi, D. C., D. J. Sheehan, P. Hogan, and D. F. Sahm. 2005. In vitro activity of linezolid against key gram-positive organisms isolated in the United States: results of the LEADER 2004 surveillance program. Antimicrob. Agents Chemother. 49:5024-5032.
10. Jones, R. N. 2003. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin. Respir. Crit. Care Med. 24:121-134.
11. Jones, R. N., T. R. Anderegg, and D. J. Biedenbach. 2003. Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinone. Clin. Microbiol. Infect. 9:543-546.
12. Jones, R. N., C. H. Ballow, and D. J. Biedenbach. 2001. Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States. Diagn. Microbiol. Infect. Dis. 40:59-66.
13. Jones, R. N., J. E. Ross, T. R. Fritsche, and H. S. Sader. 2006. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J. Antimicrob. Chemother. 57:279-287.
14. Meka, V. G., and H. S. Gold. 2004. Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39:1010-1015.
15. Mutnick, A. H., D. J. Biedenbach, J. D. Turnidge, and R. N. Jones. 2002. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn. Microbiol. Infect. Dis. 43:65-73
16. Mutnick, A. H., V. Enne, and R. N. Jones. 2003. Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. Ann. Pharmacother. 37:769-774.
17. Poppe, S., R. Schaadt, D. Sheehan, D. Sahm, G. Zurenko, and D. Shinabarger. 2006. Abstr. 106th Gen. Meet. Am. Soc. Microbiol., abstr. A-088. American Society for Microbiology, Washington, DC.
18. Potoski, B. A., J. Adams, L. Clarke, K. Shutt, P. K. Linden, C. Baxter, A. W. Pasculle, B. Capitano, A. Y. Peleg, D. Szabo, and D. L. Paterson. 2006. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin. Infect. Dis. 43:165-171.
19. Prystowsky, J., F. Siddiqui, J. Chosay, D. L. Shinabarger, J. Millichap, L. R. Peterson, and G. A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45:2154-2156.
20. Rahim, S., S. K. Pillai, H. S. Gold, L. Venkataraman, K. Inglima, and R. A. Press. 2003. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin. Infect. Dis. 36:E146-E148.
21. Sahm, D. F., D. C. Draghi, R. S. Blosser, P. A. Hogan, and D. J. Sheehan. 2005. Abstr. 105th General Meeting American Society for Microbiology, abstr. C-320. American Society for Microbiology, Washington, DC.